Clinical Trial Update: Efficacy and Safety Evaluation of Vi-sealer [NA]

View source ↗

Summary

Clinical trial update for Vi-sealer evaluating its efficacy and safety in treating benign gynecologic neoplasms; the study is currently in recruiting status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Gynecologic Neoplasm

Drugs mentioned

• Vi-sealer

Snippet

Sponsor: Hyun Park | Conditions: Benign Gynecologic Neoplasm | NA | Status: RECRUITING